| T cell–derived interferon-γ programs stem cell death in immune-mediated intestinal damage S Takashima, ML Martin, SA Jansen, Y Fu, J Bos, D Chandra, ... Science immunology 4 (42), eaay8556, 2019 | 105 | 2019 |
| Modulation of immune checkpoints and graft-versus-leukemia in allogeneic transplants by antagonizing vasoactive intestinal peptide signaling JM Li, CT Petersen, JX Li, R Panjwani, DJ Chandra, CR Giver, BR Blazar, ... Cancer research 76 (23), 6802-6815, 2016 | 21 | 2016 |
| Upregulation of HLA-E Drives Defective Natural Killer Cell Targeting in Venetoclax-Resistant Acute Myeloid Leukemia D Chandra, F Burns, Y Kosaka, S Kurtz, J Tyner, E Lind, JN Saultz Transplantation and Cellular Therapy 30 (2), S100, 2024 | | 2024 |
| Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+ Venetoclax JN Saultz, M Rai, F Burns, DJ Chandra, SK Joshi, CA Lachowiez, ... Blood 142, 5762, 2023 | | 2023 |
| Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia DJ Chandra, C Lachowiez, S Loghavi Blood Reviews, 101156, 2023 | | 2023 |
| Anthracycline induced left ventricular dysfunction in AML: A focus on the molecularly defined future of cardio-oncology. DJ Chandra, CA Lachowiez Leukemia Research 133, 107366-107366, 2023 | | 2023 |
| EP1. 01-67 Molecular Profiling of K-Ras and Its Subtypes in NSCLC Patients with Liver Metastasis D Chandra, I Eldessouki, H Mamdani, M Nagasaka, NA Karim Journal of Thoracic Oncology 14 (10), S938, 2019 | | 2019 |
| Interferon-γ Mediates Direct Intestinal Stem Cell Damage in Gastrointestinal Graft-Versus-Host Disease S Takashima, J Bos, D Chandra, SA Jansen, M O'Connor, ... Biology of Blood and Marrow Transplantation 24 (3), S68, 2018 | | 2018 |
| Response to extracorporeal photopheresis in chronic graft versus host disease correlates with levels of IL-10 producing regulatory B cells DJ Chandra, S Hosoba, C Giver, EK Waller The Journal of Immunology 196 (1_Supplement), 140.18-140.18, 2016 | | 2016 |
| Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD Z DeFilipp, M Purcell, WAC Harris, DJ Chandra, C Gleason, J Wrammert, ... Bone marrow transplantation 51 (4), 607-609, 2016 | | 2016 |
